Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Receivables (2012 - 2017)

Updated

Northwest Biotherapeutics' Receivables was $3.75 million in Q4 2017, unchanged from $3.75 million a year earlier.

Analysis

Northwest Biotherapeutics (NWBO) Receivables (2012 - 2017) Analysis & Trends

From Q2 2012 onward, Northwest Biotherapeutics has reported Receivables for 4 quarters.

  • In earlier years, Receivables was $3.75 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 3.75 Mn
Jun 30, 2017 3.75 Mn
Dec 31, 2016 3.75 Mn
Jun 30, 2012 195,000.00
API Access

Northwest Biotherapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NWBO&period=max&api_key=YOUR_API_KEY